Trial Profile
Multi-center, open-label phase II trial of CPT in MM: Phase 1
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Oct 2016
Price :
$35
*
At a glance
- Drugs Aponermin (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Actual end date (31 Oct 2008) added as reported by Chinese Clinical Trial Register record.
- 12 Apr 2012 New trial record